title: The Development of Screening Methods to Identify Drugs to Limit ER Stress Using Wild-type and Mutant Serotonin Transporter.
abstract: The function of the serotonin transporter (SERT) is regulated by its membrane trafficking. Previously, we showed that the C-terminus-deleted mutant of SERT (SERTΔCT) exhibited an aberrant membrane trafficking and subsequent retention at the endoplasmic reticulum (ER). In addition, we found that proteasome inhibitor-induced ER stress resulted in the impairment of SERT membrane trafficking and retention of SERT at the ER, an impairment very similar to that of SERTΔCT. Based on the result that the chemical chaperone 4-phnylbutulic acid (4-PBA), which relieves ER stress, accelerated the membrane trafficking and upregulated SERT activity, we hypothesized that drugs that facilitate the membrane trafficking of SERT would have potential therapeutic effects on an ER stress-related disease. In this study, we aimed to develop simple screening methods for such drugs using SERT. We first validated the serotonin uptake assay using fluorescent substrates. This simple and reliable assay method was useful for screening for drugs that affected the wild-type SERT but not SERTΔCT. In addition, we verified an assay focusing on the formation of SERTΔCT aggregates. The drugs 4-PBA and SKF-10047 facilitated the trafficking of SERT to the membrane and reduced SERTΔCT aggregates, indicating that the drugs with such characters could be potential candidates for ER stress relief. For both assays, we clarified the usefulness of a high-content screening microscope. These results could pave the way for high-throughput screening for such drugs.
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Kazusa
authors.initials: K
authors.lastname: Katarao
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Seiya
authors.initials: S
authors.lastname: Murakawa
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Masaya
authors.initials: M
authors.lastname: Asano
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Naoto
authors.initials: N
authors.lastname: Usuki
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Hikaru
authors.initials: H
authors.lastname: Yamamoto
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Shirafuji
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Shigeru
authors.initials: S
authors.lastname: Tanaka
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Izumi
authors.initials: I
authors.lastname: Hide
authors.affiliation: Department of Molecular and Pharmacological Neuroscience, Institute of Biomedical & Health Sciences, Hiroshima University , 1-2-3 Kausmi, Minami-ku, Hiroshima 734-8551, Japan.
authors.forename: Norio
authors.initials: N
authors.lastname: Sakai
keywords: ER stress; Sigma-1 receptor; chemical chaperone; membrane trafficking; serotonin transporter